JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC

Signal Transduct Target Ther. 2020 Aug 25;5(1):165. doi: 10.1038/s41392-020-00282-9.

Shu-Man Li^#^{1

2}, Li-Ru He^#¹, Jie-Wei Chen^#^{1

3}, Jie Zhou^#¹, Run-Cong Nie^#¹, Xiao-Han Jin¹, Xin Wang¹, Jian-Hua Fu^{1

4}, Feng-Wei Wang⁵, Dan Xie^{6

7}

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
² Department of Medical Oncology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Henan, PR China.
³ Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China.
⁴ Guangdong Esophageal Cancer Institute, Guangzhou, PR China.
⁵ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. wangfengw@sysucc.org.cn.
⁶ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn.
⁷ Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn.

^# Contributed equally.

No abstract available

Publication types